Copper-67 Radioisotope

Copper-67 (Cu-67) is a radioisotope used in radiopharmaceutical therapy, which is a highly targeted approach of using a radioactive drug to treat certain types of cancers. Cu-67 is injected into the bloodstream of cancer patients via an IV or catheter, allowing it to deliver precise therapeutic doses of radiation to destroy the specific cancer cells while sparing health tissue.

The Cu-67 radioisotope is manufactured at NorthStar’s proprietary Accelerator Production facility in Beloit, WI. NorthStar’s advanced technology produces clean, environmentally friendly Cu-67 and the manufacturing process has no long-lived contaminants or byproducts, which can be a major concern with radiopharmaceutical production. Once the Cu-67 is produced, it is shipped within hours to either a separate building located on NorthStar’s campus or to locations designed to combine the Cu-67 with a molecule where it will then be shipped to a hospital or outpatient center around the world. From there, the radiopharmaceutical therapy will be administered into an awaiting patient. The Cu-67 radioisotope manufactured by NorthStar Medical Radioisotopes is a potential game-changing radiopharmaceutical for cancer patients!